Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 165Congress 0Executive branch 0Insiders 165
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

TRDA · $50K+ · 165 trades

Trades
165
Buys 0 · Sells 165
People
20
Stocks
1
Disclosed value
$55.7M
range midpoints · Congress & executive
Filed late
13
  1. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
  2. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
  3. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
  4. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  5. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  6. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$159Kdisclosed Aug 26 · filed 2 days after the trade
  7. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
  8. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  9. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  10. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
  11. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$200Kdisclosed Aug 26 · filed 1 day after the trade
  12. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$159Kdisclosed Aug 26 · filed 2 days after the trade
  13. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$159Kdisclosed Aug 26 · filed 2 days after the trade
  14. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  15. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$159Kdisclosed Aug 26 · filed 2 days after the trade
  16. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$159Kdisclosed Aug 26 · filed 2 days after the trade
  17. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  18. ▼ SELLMPM Asset Management Investors BV2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$103Kdisclosed Aug 26 · filed the same day
  19. ▼ SELLKush Parmar DirectorTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  20. ▼ SELLAndrew J. Schwab 10% ownerTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade
  21. ▼ SELL5AM Partners V, LLC 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  22. ▼ SELL5AM Ventures V, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  23. ▼ SELLAndrew J. Schwab 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  24. ▼ SELL5AM Opportunities I (GP), LLC 10% ownerTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade
  25. ▼ SELLKush Parmar DirectorTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade